LPL Financial »

Biomarin Pharmaceutical shares owned by LPL Financial

Quarter-by-quarter ownership of Biomarin Pharmaceutical shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Biomarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharmaceutical held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharmaceutical by LPL Financial

Quarter filed Position value Share count Share price at filing
2025-09-30 $24k 25k 0.95
2025-06-30 $12k 13k 0.94
2025-03-31 $12k 13k 0.94
2024-12-31 $15k 16k 0.93

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Vanguard Index Fds Total Stk Mkt (VTI)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spdr Series Trust Portfolio S&p500 (SPLG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Vanguard Index Fds Growth Etf (VUG)

View all positions for LPL Financial

Top funds holding Biomarin Pharmaceutical

Tenor Capital Management
Ing Investment Management
BlackRock
MacKay Shields
Opti Capital Management
Capstone Investment Advisors
Wellesley Investment Advisors
Millennium Management
Lazard Asset Management
Oaktree Capital Management
Victory Capital Management
Bnp Paribas Arbitrage, Snc
Thrivent Financial for Lutherans
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

View all funds holding Biomarin Pharmaceutical